Skip to main content
. 2021 Mar 9;11:621373. doi: 10.3389/fonc.2021.621373

Table 1.

Correlation of Nuf2 expression and prognosis in HCC with diverse clinicopathological factors by Kaplan-Meier plotter.

Clinicopathological factors Overall survival (n = 364) Progression-free survival (n = 366)
N Hazard ratio P-value N Hazard ratio P-value
Sex Female 118 2.37(1.27–4.42) 5.3E-03 120 1.69(1.01–2.82) 0.042
Male 246 3.61(1.91–6.84) 2.4E-05 246 1.96(1.33–2.9) 5.6E-04
Grade 1 55 7.25(2.43–21.61) 6.4E-05 55 2.56(1.05–6.2) 0.033
2 174 2.01(1.2–3.36) 7.1E-03 175 2.32(1.48–3.61) 1.4E-04
3 118 3.05(1.64–5.67) 2.3E-04 119 3.27(1.19–5.61) 5.5E-06
4 12 12
Vascular invasion Yes 90 1.96(0.73–5.26) 0.17 91 2.44(1.31–4.55) 3.9E-03
None 203 2.17(1.23–3.82) 6.1E-03 204 1.44(0.88–2.38) 0.15
Race White 181 2.11(1.22–3.64) 5.9E-03 183 1.96(1.31–2.94) 8.6E-04
Asian 155 5.63(2.99–10.61) 2.4E-09 155 2.81(1.71–4.6) 2E-05
Alcohol consumption yes 115 3.01(1.4–6.46) 3.1E-03 115 2.92(1.69–5.05) 6.3E-05
none 202 2.66(1.63–4.34) 4.5E-05 204 2.03(1.31–3.13) 1.2E-03
Hepatitis virus Yes 150 1.88(0.98–3.63) 0.055 152 1.54(0.93–2.57) 0.092
None 167 3.05(1.85–5.02) 4.5E-06 167 3.06(1.92–4.87) 8.5E-07

Bold values indicate P < 0.05.